We are live on
!
Find out more
LVTX
LAVA Therapeutics
LVTX
LVTX
Delisted
LVTX was delisted on the 20th of November, 2025.
20 hedge funds and large institutions have $10.2M invested in LAVA Therapeutics in 2025 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
66% more capital invested
Capital invested by funds: $6.15M → $10.2M (+$4.06M)
5.98% more ownership
Funds ownership: 24.62% → 30.6% (+6%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
9% less funds holding
Funds holding: 22 → 20 (-2)
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
Holders
20
Holders Change
-2
Holders Change %
-9.09%
% of All Funds
0.27%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
6
Increased
3
Reduced
3
Closed
8
Calls
$68K
Puts
–
Net Calls
+$68K
Net Calls Change
+$68K
Top Buyers
| 1 |
BCM
BML Capital Management
Zionsville,
Indiana
|
+$2.18M |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$27.1K |
| 3 |
LDNAM
Lepercq De Neuflize Asset Management
New York
|
+$25.6K |
| 4 |
Two Sigma Investments
New York
|
+$9.95K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$5.59K |
Top Sellers
| 1 |
BC
Bruce & Co
Chicago,
Illinois
|
-$278K |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$86.7K |
| 3 |
EGM
Engineers Gate Manager
New York
|
-$30.4K |
| 4 |
DP
Diadema Partners
Morristown,
New Jersey
|
-$20.5K |
| 5 |
VF
Virtu Financial
New York
|
-$19K |
